← Back to headlines
Pulse Biosciences Aims for CE Mark Submission in 2026 with nPulse Platform Progress
Pulse Biosciences is targeting a CE Mark submission in 2026, driven by the advancement of its nPulse platform through various clinical milestones.
20 Feb, 07:55 — 20 Feb, 07:55
